SZodixStudyAcademic Library

Shelves Open access

Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated

Psychedelic medicine: safety and ethical concerns · Study

ArticleShelves

ArticlePsychedelic medicine: safety and ethical concerns

Brian T. Anderson2020

OA

Articlegreen2020

Psychedelic medicine: safety and ethical concerns

Brian T. Anderson · Alicia L. Danforth · Charles S. Grob

101 citations·0/0 files stored·The Lancet Psychiatry

No readable copy stored yet — this record is metadata only.

No open-access location is known for this record yet.

Literature note Cite in a project Citation map

Psychedelics and Drug Studies Ethics in Clinical Research Neuroethics, Human Enhancement, Biomedical Innovations

Abstract

No abstract was published for this record.

Paper brief

Loading…

Cite this work

Citation unavailable for this work.

BibTeX RIS CSL-JSON

No public copy is stored for this record, so only the metadata is cited.

Citations in this library

Citation map →

Stored only when both papers are in the corpus — 101 citations exist upstream.

References

2020Psychedelics and Psychedelic-Assisted Psychotherapy 2016Ego-Dissolution and Psychedelics: Validation of the Ego-Dissolution Inventory (EDI)2014LSD enhances suggestibility in healthy volunteers 2016Novel psychopharmacological therapies for psychiatric disorders: psilocybin and MDMA 2017Developing Guidelines and Competencies for the Training of Psychedelic Therapists 1954THE ROLE OF TRANSFERENCE PRACTICAL CONSIDERATIONS IN RELATION TO PSYCHOANALYTIC THERAPY

Cited by

2022Adolescent and adult time trends in US hallucinogen use, 2002–19: any use, and use of ecstasy, LSD and PCP 2022Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model 2022Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research 2022Novel ethical and policy issues in psychiatric uses of psychedelic substances 2022The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder 2024A Systematic Review of Interventions for Demoralization in Patients with Chronic Diseases

Related works

Explore the map →

Papers that cite the same references — the relational fallback while embeddings are still backfilling.

2018Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventionsreview · 3 shared references 2022Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Modelarticle · 3 shared references 2024The Psychedelic Future of Post-Traumatic Stress Disorder Treatmentreview · 3 shared references 2020Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanismsreview · 2 shared references 2018DMT Models the Near-Death Experiencearticle · 2 shared references 2022Pharmacological, neural, and psychological mechanisms underlying psychedelics: A critical reviewreview · 2 shared references

Details

Year2020

Typearticle

Published2020-09-16

VenueThe Lancet Psychiatry

ISSN-L2215-0366

Languageen

Citations101

Files0 public / 0

ShelfPsychedelics and Drug Studies

Identifiers

doi10.1016/s2215-0366(20)30146-2

openalex_workW3085274948

Links

Imported from OpenAlex (CC0) — nothing here is generated.